Filing Flows › 8-K events › THC Therapeutics
THC Therapeutics: termination of a material definitive agreement
Form 8-K filed Oct 30, 2026 · items 1.02, 5.03
What the filing says
On October 30, 2026, THC Therapeutics, Inc. (the “Company”) terminated the Share Exchange Agreement (the “Share Exchange Agreement”) originally entered into between the Company and ST Holdings Group, LLC, an Oregon limited liability company, and its related subsidiaries (“ST Holdings”), on June 20, 2025. The Company an
Read the filing on SEC EDGAR →
What usually followsAcross 2,368 8-Ks reporting Item 1.02 (termination of a material agreement) in our universe, the stock's median move the next session was 0.0% (typical size ±1.5%, up 51% of the time); over the following 21 sessions, +1.1%. Item 5.03: +0.1% next session across 5,869. Every item ranked →
What this kind of filing means
Item 1.02 — Termination of a material definitive agreement. Ending a material agreement can remove revenue, financing or a planned deal; the filing says who ended it and whether penalties apply.
Read automatically from SEC EDGAR (13F, Form 4, Form 144, Schedule 13D/G, 8-K, XBRL), House and Senate disclosures, FINRA and exchange data; errors are possible. Not investment advice.